Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

CytomX Therapeutics, Inc. - Common Stock (NQ:CTMX)

2.460 -0.050 (-1.99%)
Streaming Delayed Price Updated: 10:27 AM EDT, Jun 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 715,757
Open 2.470
Bid (Size) 2.450 (8)
Ask (Size) 2.470 (11)
Prev. Close 2.510
Today's Range 2.350 - 2.520
52wk Range 0.4000 - 2.550
Shares Outstanding 66,767,779
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Heico, Monro, Abercrombie & Fitch, Joby Aviation And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
CytomX Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Via Benzinga

Performance

YTD
+132.1%
+132.1%
1 Month
+247.5%
+247.5%
3 Month
+230.6%
+230.6%
6 Month
+156.2%
+156.2%
1 Year
+37.4%
+37.4%

More News

Read More
This CytomX Therapeutics Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday
Via Benzinga
CytomX Stock Hits 2-Month High After Upbeat Q1 Earnings, Promising Early Data For Cancer Drug
Via Stocktwits
Top movers analysis one hour before the close of the markets on 2025-05-12: top gainers and losers in today's session.
Via Chartmill
Earnings Scheduled For May 12, 2025
Via Benzinga
Exploring CytomX Therapeutics's Earnings Expectations
Via Benzinga
Monday's session: most active stocks
Via Chartmill
Stocks Under $1 to Watch: TAOP, WLGS, HIT, CTMX, JYD – Major Updates, Earnings & Offerings, More Inside….
Via AB Newswire
Topics Economy
Exposures Supply Chain
Which stocks are moving on Monday?
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
These stocks are gapping in today's session
Via Chartmill
Nano-Cap CytomX Therapeutics Stock Surges On Heels Of Cancer Data Report
Via Benzinga
Top movers in Monday's pre-market session
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Wondering what's happening in today's pre-market session?
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
These stocks are gapping in today's session
Via Chartmill
Curious about the stocks that are showing activity after the closing bell on Monday?
Via Chartmill
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Which stocks have an unusual volume on Monday?
Via Chartmill
Friday's pre-market session: top gainers and losers
Via Chartmill
Why Gap Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Earnings Scheduled For March 6, 2025
Via Benzinga

Frequently Asked Questions

Is CytomX Therapeutics, Inc. - Common Stock publicly traded?
Yes, CytomX Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does CytomX Therapeutics, Inc. - Common Stock trade on?
CytomX Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for CytomX Therapeutics, Inc. - Common Stock?
The ticker symbol for CytomX Therapeutics, Inc. - Common Stock is CTMX on the Nasdaq Stock Market
What is the current price of CytomX Therapeutics, Inc. - Common Stock?
The current price of CytomX Therapeutics, Inc. - Common Stock is 2.460
When was CytomX Therapeutics, Inc. - Common Stock last traded?
The last trade of CytomX Therapeutics, Inc. - Common Stock was at 06/05/25 10:27 AM ET
What is the market capitalization of CytomX Therapeutics, Inc. - Common Stock?
The market capitalization of CytomX Therapeutics, Inc. - Common Stock is 164.25M
How many shares of CytomX Therapeutics, Inc. - Common Stock are outstanding?
CytomX Therapeutics, Inc. - Common Stock has 164M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.